$Hoth Therapeutics (HOTH.US)$ Looking for 1.03, 1.15 and 1.29 NFA

$Hoth Therapeutics (HOTH.US)$ Will it break the 1 dollar premarket

$Hoth Therapeutics (HOTH.US)$ Reuters· just1min
Hoth Therapeutics Inc - Cancer Patient Ceases Ht-001 Treatment After One Week Due to Success

$Atara Biotherapeutics (ATRA.US)$ over 30 million cash in the books acccording to there 30th of June Financial report , will have additional extra cash of 36 million on 5 September from institutional investors and big pharma company by issuing them around 4 million shares at 8.25 $ , will further receive 20 million + 60 Million by Pierre Fabre Pharmaceuticals once FDA approves there EBV drug in Jan 2025 .
Should see increased acitivity soon as all these large investors have interest in this comp...

$MEDIROM Healthcare Technologies (MRM.US)$ Series A funding = the business capable of generating revenue and new private funding for more expansion. Let it run to 10! Series A 9bil in yen and approx >60mil USD. not financial advise

$Hoth Therapeutics (HOTH.US)$ Beat the shorties , this stock fair value is 4 $ . short sellers are suppressing this stock for a long time even today as it starts to squeeze , it's time to turn tables on them

$Hoth Therapeutics (HOTH.US)$
What are they up to ?

$Hoth Therapeutics (HOTH.US)$
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
Hoth Therapeutics (NASDAQ: HOTH) has entered a Master Services Agreement with Aronnax Inc. for its HT-KIT cancer therapeutic.
Aronnax will oversee ITR Laboratories in conducting intravenous injection studies to determine the Maximum-Tolerated Dose (MTD) and perform a Dose Range-Finding Phasefor HT-KIT.
HT-KIT, an antisense oligonucleotide targeting the proto-oncoge...

$Hoth Therapeutics (HOTH.US)$ Beat the shorties , this stock fair value is 4 $ . short sellers are suppressing this stock for a long time even today as it starts to squeeze , it's time to turn tables on them